|
|
|
Volumn 17, Issue 4, 1998, Pages 335-340
|
|
The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CHOLESTEROL;
CYCLOSPORIN;
LIPID;
METHYLPREDNISOLONE;
PRAVASTATIN;
PREDNISONE;
ADULT;
ALLOGRAFT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOTOXIC T LYMPHOCYTE;
CYTOTOXICITY;
DRUG POTENTIATION;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART MUSCLE BIOPSY;
HEART TRANSPLANTATION;
HUMAN;
HUMAN CELL;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MIXED LYMPHOCYTE REACTION;
NATURAL KILLER CELL;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ADJUVANTS, IMMUNOLOGIC;
ANTICHOLESTEREMIC AGENTS;
CELLS, CULTURED;
CHOLESTEROL;
CHOLESTEROL, LDL;
CORONARY DISEASE;
CYCLOSPORINE;
DISEASE PROGRESSION;
DRUG SYNERGISM;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
IMMUNOSUPPRESSIVE AGENTS;
INCIDENCE;
KILLER CELLS, NATURAL;
MALE;
MIDDLE AGED;
PRAVASTATIN;
T-LYMPHOCYTES, CYTOTOXIC;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 0031969035
PISSN: 10532498
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (105)
|
|
References (15)
|
